C4 Therapeutics (CCCC)
Develops targeted-protein degraders for oncology through TORPEDO.
$3.31
After hours0.00 (0.00%)
At close$3.31(+0.30%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
estimated · in 44 days
EPS estimate
−$0.21
Revenue estimate
$8.8M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$0.49−$0.37−$0.37−$0.44−$0.18−$0.20−$0.18Pending
Estimate−$0.45−$0.48−$0.38−$0.41−$0.31−$0.25−$0.23−$0.21
Surprise−8.9%+22.9%+2.6%−8.5%+41.9%+20.2%+20.5%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$5.2M$7.2M$6.5M$11.2M$11.0M$6.2M$6.6MPending
Estimate$5.1M$4.5M$6.6M$6.3M$5.4M$4.4M$4.0M$8.8M
Surprise+1.7%+61.8%−1.3%+78.3%+104.2%+40.4%+66.0%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.27 | — | — |
| Sep 2027 | −$0.27 | — | — |
| Jun 2027 | −$0.23 | — | — |
| Mar 2027 | −$0.27 | — | — |
| Dec 2026 | −$0.29 | — | — |
| Nov 2026 | −$0.21 | — | — |
| Aug 2026 | −$0.23 | −$0.18 | +20.5% |
| May 2026 | −$0.25 | −$0.20 | +20.2% |
| Feb 2026 | −$0.31 | −$0.18 | +41.9% |
| Nov 2025 | −$0.41 | −$0.44 | −8.5% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Oct 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.27 | — | — | $5.0M | — | — | — |
| Sep 2027 | −$0.27 | — | — | $5.0M | — | — | — |
| Jun 2027 | −$0.23 | — | — | $5.0M | — | — | — |
| Mar 2027 | −$0.27 | — | — | $5.0M | — | — | — |
| Dec 2026 | −$0.29 | — | — | $4.0M | — | — | — |
| Nov 5, 2026 | −$0.21 | — | — | $8.8M | — | — | — |
| Aug 11, 2026 | −$0.23 | −$0.18 | +20.5% | $4.0M | $6.6M | +66.0% | +6.9% |
| May 12, 2026 | −$0.25 | −$0.20 | +20.2% | $4.4M | $6.2M | +40.4% | 0.0% |
| Feb 26, 2026 | −$0.31 | −$0.18 | +41.9% | $5.4M | $11.0M | +104.2% | +0.4% |
| Nov 6, 2025 | −$0.41 | −$0.44 | −8.5% | $6.3M | $11.2M | +78.3% | +0.4% |
| Aug 7, 2025 | |||||||
| May 6, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Oct 31, 2024 | |||||||
| Aug 1, 2024 | |||||||
| May 8, 2024 | |||||||
| Feb 21, 2024 | |||||||
| Nov 1, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 4, 2023 | |||||||
| Feb 23, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 5, 2022 | |||||||
| Feb 24, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Aug 11, 2021 | |||||||
| May 13, 2021 | |||||||
| Mar 11, 2021 | |||||||
| Nov 12, 2020 | |||||||
| Oct 2, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 |